Taken together, the results of this study demonstrated that SS can prevent and protect against scopolamine-induced memory impairment by regulating the NGF-BDNF-CREB signaling pathway (Figure 9) and inhibiting AChE expression. Here, CREB1 is linked to memory impairment.